Citius Pharmaceuticals, Inc. — Director's Dealing 2015

Oct 28, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2014-09-12-06:00

Reporting Person: Mazur Leonard L (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	457143	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$0.45	2024-09-12-06:00	Common Stock (1800000)		Direct

Footnotes

F1: The option granted shall vest and become exercisable as follows: the option to purchase 300,000 shares of common stock of the Company (the "Common Stock") vested on September 12, 2014, the option to purchase 500,000 shares of Common Stock vested on September 12, 2015; the option to purchase 500,000 shares of Common Stock shall vest on March 12, 2016; the option to purchase 500,000 shares of Common Stock shall vest on September 12, 2016; and the option to purchase 500,000 shares of Common Stock shall vest on September 12, 2017. The maximum number of shares of Common Stock subject to the grant shall be 3,300,000. The option was issued pursuant to the Company's 2014 Stock Incentive Plan.